Bryostatin seen as treatment of Alzheimer's in addition to cancer

07/28/2004 | NYTimes.com

Researchers looking at bryostatin as a treatment for cancer now believe the drug also slows memory loss and helps prevent Alzheimer's disease. The drug has been approved by the FDA for cancer trials, but researchers are looking ahead to Alzheimer's trials after seeing bryostatin break down proteins responsible for amyloid plaques, the brain deposits associated with the disease.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC